Keay Nakae, CFA

Keay Nakae is a Senior Research Analyst at Chardan. Mr. Nakae has over 17 years of experience as a sell-side research analyst covering healthcare companies, and has previously worked at Wedbush Morgan, and CE Unterberg Towbin/Collins Stewart.

Mr. Nakae has made numerous media appearances on Bloomberg TV, and has been quoted in publications such as The Wall Street Journal, Time, Business Week, and The Los Angeles Times. He has been recognized by Forbes magazine in its annual survey of America’s Best Analysts.

Mr. Nakae earned an MBA degree from UCLA’s Anderson School of Management, and holds MS and BS degrees in electronic engineering from Cal Poly. Mr. Nakae is a CFA charterholder and a member of the CFA Institute.

  • Biotechnology & Pharmaceuticals Research Coverage

    Company NameTicker

    AB Science S.A.

    AB.FP

    Alnylam Pharmaceuticals, Inc.

    ALNY

    Arbutus Biopharma Corporation

    ABUS

    Arrowhead Pharmaceuticals, Inc.

    ARWR

    Avidity Biosciences, Inc.

    RNA

    Coya Therapeutics

    COYA

    Dyne Therapeutics Inc.

    DYN

    Gain Therapeutics, Inc.

    GANX

    Omega Therapeutics, Inc.

    OMGA

    ProQR Therapeutics NV

    PRQR

    SAB Biotherapeutics, Inc.

    SABS

    Seres Therapeutics, Inc.

    MCRB

    Silence Therapeutics PLC

    SLN

    Sonnet BioTherapeutics Holdings, Inc.

    SONN

    Synlogic, Inc.

    SYBX

  • Therapeutics, Devices & Diagnostics Research Coverage

    Company NameTicker

    Allurion Technologies Inc.

    ALUR

    Femasys, Inc.

    FEMY

    Notable Labs, Ltd.

    NTBL

    Orchestra BioMed Inc.

    OBIO

See all research

Thank You!

We've received your information, and we're processing your request.

Get In Touch.

One Pennsylvania Plaza
Suite 4800
New York, NY 10119

One East Putnam Ave, 4th Fl. Greenwich, CT 06830

+1 646-465-9000

All fields required
SUBMIT